Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

The chicken 2'-5' oligoadenylate synthetase A inhibits the replication of West Nile virus.

Tag-El-Din-Hassan HT, Sasaki N, Moritoh K, Torigoe D, Maeda A, Agui T.

Jpn J Vet Res. 2012 Aug;60(2-3):95-103.

PMID:
23094584
2.

The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells.

Kajaste-Rudnitski A, Mashimo T, Frenkiel MP, Guénet JL, Lucas M, Desprès P.

J Biol Chem. 2006 Feb 24;281(8):4624-37. Epub 2005 Dec 21.

3.

Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b.

Mertens E, Kajaste-Rudnitski A, Torres S, Funk A, Frenkiel MP, Iteman I, Khromykh AA, Desprès P.

Virology. 2010 Mar 30;399(1):176-85. doi: 10.1016/j.virol.2009.12.036. Epub 2010 Jan 25.

4.

Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.

Graham JB, Thomas S, Swarts J, McMillan AA, Ferris MT, Suthar MS, Treuting PM, Ireton R, Gale M Jr, Lund JM.

MBio. 2015 May 5;6(3):e00493-15. doi: 10.1128/mBio.00493-15.

5.

Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b protein.

Lucas M, Mashimo T, Frenkiel MP, Simon-Chazottes D, Montagutelli X, Ceccaldi PE, Guénet JL, Desprès P.

Immunol Cell Biol. 2003 Jun;81(3):230-6.

6.

Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.

Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B, Johnson H, Pape J, Foster GA, Krysztof D, Follmann D, Stramer SL, Margolis LB, Murphy PM.

PLoS Pathog. 2009 Feb;5(2):e1000321. doi: 10.1371/journal.ppat.1000321. Epub 2009 Feb 27.

7.

Transgenic expression of full-length 2',5'-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis.

Simon-Chazottes D, Frenkiel MP, Montagutelli X, Guénet JL, Desprès P, Panthier JJ.

Virology. 2011 Aug 15;417(1):147-53. doi: 10.1016/j.virol.2011.05.018. Epub 2011 Jun 17.

8.

OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses.

Rios JJ, Fleming JG, Bryant UK, Carter CN, Huber JC, Long MT, Spencer TE, Adelson DL.

PLoS One. 2010 May 7;5(5):e10537. doi: 10.1371/journal.pone.0010537.

9.

Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection.

Yakub I, Lillibridge KM, Moran A, Gonzalez OY, Belmont J, Gibbs RA, Tweardy DJ.

J Infect Dis. 2005 Nov 15;192(10):1741-8. Epub 2005 Oct 12.

PMID:
16235172
10.

RNase L plays a role in the antiviral response to West Nile virus.

Scherbik SV, Paranjape JM, Stockman BM, Silverman RH, Brinton MA.

J Virol. 2006 Mar;80(6):2987-99.

11.

[OAS genes and susceptibility to West Nile virus].

Guénet JL, Després P.

Med Sci (Paris). 2003 Jan;19(1):9-12. French. No abstract available.

12.
13.

Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen.

Gu B, Ouzunov S, Wang L, Mason P, Bourne N, Cuconati A, Block TM.

Antiviral Res. 2006 Jun;70(2):39-50.

PMID:
16724398
14.

2'-5'-Oligoadenylate Synthetase-Like Protein Inhibits Respiratory Syncytial Virus Replication and Is Targeted by the Viral Nonstructural Protein 1.

Dhar J, Cuevas RA, Goswami R, Zhu J, Sarkar SN, Barik S.

J Virol. 2015 Oct;89(19):10115-9. doi: 10.1128/JVI.01076-15. Epub 2015 Jul 15.

15.

Glycosylation of the envelope protein of West Nile Virus affects its replication in chicks.

Totani M, Yoshii K, Kariwa H, Takashima I.

Avian Dis. 2011 Dec;55(4):561-8.

PMID:
22312974
16.

West Nile virus: immunity and pathogenesis.

Lim SM, Koraka P, Osterhaus AD, Martina BE.

Viruses. 2011 Jun;3(6):811-28. doi: 10.3390/v3060811. Epub 2011 Jun 15. Review.

17.

Activation of 2' 5'-oligoadenylate synthetase by stem loops at the 5'-end of the West Nile virus genome.

Deo S, Patel TR, Dzananovic E, Booy EP, Zeid K, McEleney K, Harding SE, McKenna SA.

PLoS One. 2014 Mar 20;9(3):e92545. doi: 10.1371/journal.pone.0092545. eCollection 2014.

18.

The innate immune playbook for restricting West Nile virus infection.

Quicke KM, Suthar MS.

Viruses. 2013 Oct 30;5(11):2643-58. doi: 10.3390/v5112643. Review.

19.

Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection.

Thackray LB, Shrestha B, Richner JM, Miner JJ, Pinto AK, Lazear HM, Gale M Jr, Diamond MS.

J Virol. 2014 Oct;88(19):11007-21. doi: 10.1128/JVI.01545-14. Epub 2014 Jul 16.

20.

IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection.

Ramos HJ, Lanteri MC, Blahnik G, Negash A, Suthar MS, Brassil MM, Sodhi K, Treuting PM, Busch MP, Norris PJ, Gale M Jr.

PLoS Pathog. 2012;8(11):e1003039. doi: 10.1371/journal.ppat.1003039. Epub 2012 Nov 29.

Supplemental Content

Support Center